# Sunshine Biopharma Inc.: Form 8-K, filed Oct 20, 2022

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K
- Filed: 2022-10-20
- Accepted by EDGAR: Oct 20, 2022, 07:30 ET
- Period: 2022-10-20
- Accession: 0001683168-22-006971
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316822006971/sunshine_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316822006971/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316822006971/sunshine_8k.htm

Filed Oct 20, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-006971. Last ingested by Listed: Nov 13, 2026, 16:19 ET. No prices; not investment advice.